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Abstract
Introduction: Octamer-binding transcription factor 4 (Oct4) is a master regulator of early mammalian
development. Its expression begins from the oocyte stage, becomes restricted to the inner cell mass of the
blastocyst and eventually remains only in primordial germ cells. Unearthing the interactions of Oct4 would provide
insight into how this transcription factor is central to cell fate and stem cell pluripotency.
Methods: In the present study, affinity-tagged endogenous Oct4 cell lines were established via homologous
recombination gene targeting in embryonic stem (ES) cells to express tagged Oct4. This allows tagged Oct4 to be
expressed without altering the total Oct4 levels from their physiological levels.
Results: Modified ES cells remained pluripotent. However, when modified ES cells were tested for their
functionality, cells with a large tag failed to produce viable homozygous mice. Use of a smaller tag resulted in
mice with normal development, viability and fertility. This indicated that the choice of tags can affect the
performance of Oct4. Also, different tags produce a different repertoire of Oct4 interactors.
Conclusions: Using a total of four different tags, we found 33 potential Oct4 interactors, of which 30 are novel. In
addition to transcriptional regulation, the molecular function associated with these Oct4-associated proteins
includes various other catalytic activities, suggesting that, aside from chromosome remodeling and transcriptional
regulation, Oct4 function extends more widely to other essential cellular mechanisms. Our findings show that
multiple purification approaches are needed to uncover a comprehensive Oct4 protein interaction network.
Introduction
Octamer-binding transcription factor 4 (Oct4) [1], also
termed Oct3 or Pou5f1 [2], is an early developmental
stage transcription factor. Oct4 expression begins in the
oocyte from maternal sources and is continued by zygotic
expression after the four-cell stage. Thereafter it becomes
restricted to the inner cell mass, the epiblast and even-
tually the germ cells [3]. During this time, Oct4 expression
serves to regulate pluripotency and cell fate development
[4]. Oct4-null mouse embryos become restricted to a tro-
phectoderm lineage at the blastocyst stage, leading to peri-
implantation lethality [5]. Such cell fate restriction is also
observable in mouse embryonic stem (ES) cells when Oct4
levels decrease to less than 50% of the normal diploid
expression. On the other hand, an increase in Oct4 levels
by 50% converts ES cells to a primitive endodermal and
mesodermal fate [6,7]. Hence, the maintenance of pluripo-
tency requires Oct4 to be present within a very narrow
concentration range, and a change in Oct4 levels directs
cells to different developmental fates. Oct4 with combina-
tions of the following factors (Klf4, c-Myc, Sox2 and
Esrrb) were also shown to be sufficient to induce pluripo-
tency in various differentiated cell types [8-10]. Therefore,
Oct4 is one of the key transcription factors involved in
both the maintenance of ES cell pluripotency [11,12] and
somatic cell reprogramming [10,13-17]. Oct4 performs its
role via switching target genes on or off. Chromatin
immunoprecipitation experiments and in silico analyses of
Oct4 have identified at least 420 target genes with putative
Oct4-binding motifs [18-21]. These target genes span mul-
tiple biological processes and developmental stages. Regu-
lation of these different genes (including Pou5f1 itself) has
been shown to be mediated via Oct4 interaction with
other transcription factors [22-24]. To better understand
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s t u d i e so ni t sp r o t e i ni n t eraction network have been
attempted [25-28], and they have shown that Oct4 associ-
ates with other transcription factors and epigenetic regula-
tors [25-28]. Here we aim to further elucidate the Oct4
interaction network using a different approach. Unlike ear-
lier studies, our study targets the endogenous Oct4 allele.
This approach eliminates the altering of Oct4 from its
physiological levels. Although previous studies strove to
keep changes in Oct4 levels within perceived limits for ES
cell maintenance, it is unknown whether this minor
increase in dosage would affect embryonic development.
This is a very real concern, since modulating Oct4 levels is
an intrinsic mechanism used by the embryo to control cell
fate [6].
The two most recent studies on the Oct4 interactome
[26,27] showed an overlap of about 40% of the smaller
set. Is the real Oct4 interactome therefore a union or
intersection of these data [29], and are these data sets
sufficiently saturated to describe the Oct4 interactome?
Since identical tags were used, differences between the
data sets were attributed to the different preparations of
ES cells. Pardo et al. [26] extracted total ES cell lysate in
a gentle buffer using mechanical disruption, and van den
Berg et al. [27] extracted only the nuclear extract using
a high salt extraction method. Differences in data pro-
cessing were another factor. These suggest that the type
of interactors discovered is highly dependent on all of
the experimental conditions and parameters. Therefore,
the need for future studies to boost the confidence of
proteins in these data sets remained [29]. Our study
indicates that the Oct4 interactome can be expanded by
varying purification conditions through the use of differ-
ent tags to the same endogenous Oct4 protein. In all, 33
Oct4-associated proteins were identified in our study,
and they associate with proteins beyond transcriptional
regulatory modules. This indicates that Oct4 may utilize
self-modification as a means of transcriptional regula-
tion or may even be involved in other types of cellular
processes alongside transcriptional regulation.
Materials and methods
Gene targeting of ES cell lines via homologous
recombination
V6.4 (C57BL/6 × 129/Sv) ES cells [30] were used for gene
targeting as previously described [31]. The targeting vec-
tor was constructed by inserting a floxed neo selection
cassette (loxP-PGK-Gb2-neo-loxP) in the 5’ untranslated
region of the Pou5f1 (Oct3/4) gene in a mouse bacterial
artificial chromosome (BAC) and insertion of a unique
FseI site immediately downstream of the translation start
site of the Pou5f1 gene. Dual tags were inserted in-frame
with Pou5f1 via the FseI site. Four different constructs
bearing the dual tags protein A calmodulin-binding
peptide (CBP), biotin acceptor peptide (BAP)-6xHIS,
S-CBP and 2xFLAG-6xHIS were made. These final con-
structs were used to generate the four separately tagged
Oct4 ES cell lines expressing N-terminal tandem affinity
purification (NTAP)-Oct4, N-terminal BAP-HIS (NBH)-
Oct4, N-terminal S peptide CBP (NSC)-Oct4 and N-
terminal FLAG-HIS (NFH)-Oct4. The neo selection cas-
sette was removed by transient expression of Cre recom-
binase. For the NBH-Oct4 cell line, a second targeting
vector (pROSA26-hBirA-lacZ-loxP-neo, courtesy of M.
Lee) was introduced. This vector bears a “humanized”
BirA ligase (hBirA) gene, as well as neo and lacZ markers,
at the Rosa26 locus.
Generation of genetically modified mice
NTAP-Oct4 and NSC-Oct4 ES cells were injected into
blastocysts and used to generate tagged Oct4 chimeras
that were then used to derive heterozygous and homozy-
gous animals. The Institutional Animal Care and Use
Committee at our institution approved all animal proto-
cols used in this study.
Affinity purification
ES cell lines for protein purification were grown without
Mouse Embryo Fibroblasts (MEF). Nuclear proteins were
extracted using NE-PER Reagents (Pierce Biotechnology/
Thermo Scientific, Waltham, Massachusetts, USA)
according to the manufacturer’s instructions. Nuclear
extracts were buffer-exchanged using Zeba Spin Desalt-
ing Columns (Pierce Biotechnology/Thermo Scientific)
prior to purification. For S-tag purification, nuclear
extract was incubated with S-protein agarose beads
(Novagen, Darmstadt, Germany) in binding buffer
(20 mM Tris·HCl, pH 7.5, 150 mM NaCl, 0.2% Triton
X-100 and 5% glycerol), washed with four column
volumes (CVs) of binding buffer and eluted with 1.4 mg/
mL S peptide, KETAAAKFERQHMDS (customized pep-
tide synthesis by Sigma, St. Louis, Missouri), in binding
buffer. For FLAG-tag purification, nuclear extract was
incubated with ANTI-FLAG M2 Affinity Gel (Sigma) in
binding buffer (50 mM Tris·HCl, pH 7.4, and 150 mM
NaCl), washed with five CVs of binding buffer and eluted
with 0.1 mg/mL of 3XFLAG peptide, MDYKDHDG-
DYKDHDIDYKDDDDK (Sigma), in binding buffer. For
HIS-tag purification, nuclear extract was incubated with
Ni-NTA Superflow (Qiagen, Venlo, Netherlands) in bind-
ing buffer (20 mM Tris·HCl, pH 7.9, 350 mM NaCl, 0.2%
Triton X-100 and 10 mM imidazole), washed in one CV
of wash buffer, followed by two CVs of binding buffer
with increased imidazole (20 mM) before elution with
300 mM imidazole in pH 7.0 binding buffer. For CBP-
tag purification, nuclear extract was incubated with
calmodulin-agarose (Millipore, Billerica, Massachusetts,
USA) in binding buffer (10 mM Tris·HCl, pH 8.0,
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CaCl2, 0.1% Nonidet P (NP)-40 and 10 mM b-mercap-
toethanol), washed in three CVs of wash buffer (50 mM
T r i s · H C l ,p H7 . 0 ,3 5 0m MN a C l ,0 . 2 %N P - 4 0a n d
5 mM imidazole) before elution via release of the HIS-
tagged calmodulin with elution buffer (50 mM Tris·HCl,
pH 7.0, 350 mM NaCl, 0.1% NP-40 and 350 mM imida-
zole). All buffers used in protein extraction and affinity
purification were supplemented with Complete Protease
Inhibitor EDTA-free Cocktail (Roche, Indianapolis, IN,
USA). All resins were equilibrated in binding buffer
before use. The incubation time of nuclear extract with
resin ranged from 1.5 hours to overnight at 4°C.
Western blot analysis
Analyses were performed by resolving ES nuclear
extraction or unbound, washed and eluted fractions
from the purifications on gradient (4% to 15%) or 10%
acrylamide gels by sodium dodecyl sulfate polyacryla-
mide gel electrophoresis (SDS-PAGE), followed by
transfer of the proteins onto polyvinylidene difluoride
membranes for detection with relevant antibodies. The
antibodies used were anti-Oct4 antibodies (ab27985;
Abcam, Boston MA, USA), anti-S antibodies (sc-802;
S a n t aC r u zB i o t e c h n o l o g y ,S a n t aC r u z ,C A ,U S A ) ,a n t i -
6xHIS monoclonal antibody horseradish peroxidase
(HRP) conjugate (631210; Clontech, Mountain View,
CA, USA), anti-CBP (sc-33000; Santa Cruz Biotechnol-
ogy) and anti-FLAG M2 monoclonal antibodies (F3165
or F1804; Sigma). Unlabeled primary antibodies were
detected by using HRP-linked antirabbit antibody
(NA934; GE Healthcare Life Sciences, GE Healthcare
Pte Ltd., Life Sciences Consumables, Singapore, Singa-
pore), HRP-linked antimouse antibody (NXA931; GE
Healthcare Life Sciences) or HRP-linked antigoat anti-
body (sc-2020; Santa Cruz Biotechnology). BAP tag was
detected by using streptavidin-HRP (NEL750; PerkinEl-
mer, Waltham Massachusetts, USA).
Mass spectrometry
Proteins eluted by affinity purification were resolved by
SDS-PAGE and Coomassie-stained with SimplyBlue Safe-
Stain (Invitrogen, Carlsbad, California, USA). Each gel
lane was cut into five sections. Gel pieces were subjected
to in-gel tryptic digestion. Each section was submitted as
an individual sample for liquid chromatography-mass
spectrometry (LC-MS/MS) analysis at the Genome Insti-
tute of Singapore proteomic facility. Samples were
injected using a nano-LC pump to a reversed-phase col-
umn and analyzed by using an LTQ-MS/MS spectro-
meter (ThermoFinnigan, San Jose, CA, USA). LC-MS/
MS spectra from each purification were identified using
both SEQUEST and X!Tandem search engine algorithms.
The results were then loaded onto the Scaffold Proteome
Software platform (Proteome Software, Inc., Portland,
OR, USA), and the parameters of 95% probability of cor-
rect protein and peptide identification were set as filters.
Results
Endogenous tagged Oct4 cell lines express tagged Oct4
at physiological levels and remain pluripotent
To look at Oct4 interacting proteins, we tagged the endo-
genous Oct4/Pou5f1 locus via homologous recombination
(Figure 1A). Four different mouse ES cell lines were gener-
ated, each with two different affinity tags targeted to the
N-terminal of Oct4. Targeting to the correct locus was
verified by Southern blot analysis (Figure 1B) using a
probe that lies outside the left homology arm (Figure 1A).
The results show the presence of an expected shorter frag-
ment of 6.7 kb coming from the tagged allele in addition
to the 11.7-kb fragment from the unmodified allele for
modified ES cells (Figure 1B). Correctly modified ES cells
are annotated Oct4
WT/TAG, and the proteins expressed are
annotated NTAP-Oct4, NSC-Oct4, NFH-Oct4 and NBH-
Oct4 (Figure 1C). The tagged Oct4 proteins that would be
expressed from each of the cell lines have a span of various
sizes, ranging from 41 kDa to 58 kDa, making the tagged
proteins 3 kDa to 20 kDa bigger than Oct4.
Expression levels of the various tagged Oct4 proteins
from each of the four cell lines were verified by Western
blot analysis (Figures 2A through 2E). Expression was not
observed until the neomycin cassette, which was inserted
between the endogenous Oct4 promoter and the transla-
tional start site of NTAP-Oct4,w a sr e m o v e d .T h el a r g e
differences between the tagged and wild-type Oct4 sizes in
the Oct4
WT/NTAP cell line enabled us to examine the levels
of tagged Oct4 relative to wild type using anti-Oct4 anti-
bodies. The levels are visually equivalent, confirming that
the endogenously modified Oct4 gene retained normal
levels of protein expression. It is unknown why a doublet
is observed. One possibility is the posttranslational modifi-
cation of Oct4, since this is also observed in the wild-type
sample. For the small tagged Oct4 cell lines, loading an
equal volume of total nuclear extract as wild-type ES cells
produced comparable intensity when detected by anti-
Oct4 antibody, suggesting that the level of Oct4 is also
unaltered (Figure 2B).
Expression of the tags was confirmed by using anti-S
antibody (Figure 2C) and anti-FLAG antibody (Figure 2D)
for the NSC-Oct4- and NFH-Oct4-expressing cell lines,
respectively. For the NBH-Oct4 expressing cell line, detec-
tion of the BAP tag was verified by using streptavidin
(Figure 2E).
To evaluate the effect of each of these tags on ES cell
character, we stained each of the four cell lines for alka-
line phosphatase activity. All tagged cell lines stained
similarly to the wild type (Figure 2F) and exhibited mor-
phology and passage times similar to those of wild-type
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affect ES cells.
NTAP-Oct4 cell line produces a lethal phenotype
Although all tagged ES cell lines performed equally well
in culture, the ability of tagged Oct4 to drive the forma-
tion of a whole animal was never verified. We checked
for full Oct4 functionality by generating tagged Oct4
m i c e .S i n c el a r g et a g sa r em o r el i k e l yt oa f f e c tp r o t e i n
function, we picked Oct4-tagged cell lines with the two
largest tags, NTAP and NSC, for in vivo assessment.
Mice were derived by blastocyst injection of the modi-
fied ES cells, and chimeric mice were bred to obtain
heterozygous and homozygous offspring. We obtained a
non-Mendelian ratio of live births for the offspring of
Oct4
WT/NTAP crosses. At two weeks of age, when mice
were genotyped, there was only one Oct4
NTAP/NTAP
mouse (Table 1). This mouse died prior to sexual
maturity. These results suggest that there was loss of
function associated with the insertion of the NTAP tag
at Oct4. Similar mating with Oct4
WT/NSC animals, how-
ever, resulted in offspring at numbers close to expected
ratios. c
2 testing of the data showed that the number of
homozygous NSC-tagged pups obtained was consistent
with the expected Mendelian ratio (Additional file 1).
More importantly, Oct4
NSC/NSC homozygous mice were
viable and fertile, suggesting that the insertion of the
NSC tag at Oct4 did not disrupt development. Since the
Figure 1 Construction of endogenous affinity-tagged Oct4/Pou5f1 alleles by gene-targeted homologous recombination in embryonic
stem cells. (A) Each of four different gene-targeting constructs comprising dual-affinity tags was constructed to target the endogenous
Oct4/Pou5f1 allele. NTAP (protein A calmodulin-binding peptide), NSC (S peptide calmodulin-binding peptide), NBH (biotin acceptor peptide-HIS)
or NFH (FLAG-HIS) was inserted at the ATG translation start site of Oct4. The wild-type Oct4 allele gives an 11.7-kb restriction fragment during
digestion with EcoRI, whereas correctly targeted homologous recombination results in a mutant Oct4 allele that gives a 6.5-kb fragment instead.
These fragments were detected using an external probe that lies between the EcoRI site and the HpaI site. (B) Southern blot analysis of
embryonic stem (ES) cell colonies after endogenous Oct4 modification with the targeting construct for introduction of NTAP tag. Wild-type (WT)
Oct4 BAC and NTAP-Oct4 BAC were used as positive controls for the wild-type allele fragment and the mutant allele fragment, respectively. The
probe used is indicated in Figure 1A. (C) Diagram showing the proteins that are expressed by the respective modified Oct4 alleles. NBH,
N-terminal biotin acceptor peptide HIS; NFH, N-terminal FLAG HIS; NSC, N-terminal S peptide calmodulin-binding peptide; NTAP, N-terminal
tandem affinity purification; BAP, biotin acceptor peptide; CBP, calmodulin-binding peptide; S, S peptide; TEV, tobacco etch virus.
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we proceeded with affinity purifications using only three
of the four original cell lines: Oct4
WT/NSC,O c t 4
WT/NFH
andOct4
WT/NBH. Given the even smaller size of the NFH
and NBH tags and the identical position of tag insertion
in all tag variants, we postulated that these two tag var-
iants would also would not be deleterious to Oct4 func-
tion as the NSC tag was.
Identification of Oct4 interacting proteins
In contrast to researchers in other studies, we identified
Oct4 interacting proteins using four different affinity-tag
purification approaches. The advantage of this method
is that the protein interactors discovered are not limited
by the conditions of one approach. Western blot analy-
sis of the purification was used to detect the tagged
Oct4 following purification from Oct
WT/TAG or from
wild-type ES cells as starting material. An example of
purification for the S tag (Figure 2G) shows that Oct4 is
enriched only in the tagged ES cell line, but not in the
wild-type ES cell line. Detection using anti-S antibody
confirmed the presence of the tag in the enriched Oct4,
while detection for tubulin suggested a depletion of
background protein after purification amid the enrich-
ment of NSC-Oct4. Following affinity purification, elu-
ates were separated by gel electrophoresis. Whole lanes
were excised into multiple gel bands and subjected to
further tryptic digestion and peptide identification by
Figure 2 Modified ES cells show proper expression of both wild-type and affinity-tagged alleles. (A and B) Expression of NTAP-Oct4, NSC-Oct4
and NFH-Oct4 detected by anti-Oct4 shows amount of Oct4 equivalent to that found in wild-type ES cells. (C) Expression of NSC-Oct4 detected by
anti-S antibody. (D) Expression of NFH-Oct4 detected by anti-FLAG antibody. (E) Expression of NBH-Oct4 was detected by using streptavidin-
horseradish peroxidase (HRP). Wild-type ES cells were loaded as negative controls. (F) Alkaline phosphatase (AP) staining shows that modified ES cells
are pluripotent like control Oct4
WT/WT ES cells. (G) S-tag affinity purification was performed on Oct4
WT/NSC ES cells and Oct4
WT/WT ES cells. Western blot
analysis was performed on the nuclear lysate (L) as well as on the unbound (U) fraction, the first wash (W1), the last wash (W4), the eluate (E) and the
boiled beads (B) after elution of the purification process. The marker sizes are indicated in kilodaltons. Anti-b tubulin was used as a control.
Table 1 Number and percentage of pups belonging to each genotype as a result of mating heterozygotes
a
Heterozygote mating
Oct4
WT/NTAP Oct4
WT/NSC
Mating type Number (%) App Number (%) App
Wild-type pups (Oct4
WT/WT) 25 (34.2%) WT 41 (27.7%) WT
Heterozygous pups (Oct4
WT/TAG) 47 (64.4%) WT 82 (55.4%) WT
Homozygous pups (Oct4
TAG/TAG) 1 (1.4%) † 25 (16.9%) WT
Total 73 (100%) 148 (100%)
aNTAP, N-terminal tandem affinity purification; NSC, N-terminal S peptide CBP; App (appearance), longevity and fertility; WT, wild type. † = animal died
Cheong et al. Stem Cell Research & Therapy 2011, 2:26
http://stemcellres.com/content/2/3/26
Page 5 of 11LC-MS/MS. Raw MS/MS data were subjected to protein
identification by searches using the mouse International
Protein Index database (European Bioinformatics Insti-
tute, Cambridge, UK). Only proteins identified in the
overlap of two separate algorithm searches (Sequest and
X!Tandem) were considered confident identifications
and pursued for further analysis.
Although a true interactor may be found in only one
of the four different approaches, we considered only
proteins that were enriched by at least two approaches
to keep the list robust. For better comparison with pre-
vious publications, we also used the same cutoff value:
Accepting proteins are not detected in the control puri-
fications or are threefold the control purifications or
greater. On the basis of these criteria, we compiled a list
comprising 33 potential Oct4 interactors (Table 2 and
Additional file 2). To compare proteins identified by
using different approaches with those identified by
FLAG-tag purification, we overlapped the proteins in
our experiment with those described in two previous
studies [26,27]. Those two studies represent the most
current and largest sets of Oct4 interactors identified by
purification of a FLAG-tagged Oct4 transgene. Only
three of our proteins (cullin 4B, importin subunit a2
and DNA topoisomerase 2a)o v e r l a p p e dw i t ht h ep r o -
teins described in the study published by Pardo et al.
[26], while none of our proteins overlapped with those
described in the study reported by van den Berg et al.
[27] (Figure 3A). Since the two previous studies showed
20 proteins that overlapped with each other, our pro-
teins’ degree of overlap with the proteins reported by
Pardo et al. [26] is considerably smaller than that
between studies using the same tag purifications. Con-
sistent with this observation is that tandem purifications
using two different tags resulted in only seven common
proteins when results from a tandem FLAG-tag and
CBP-tag purification were compared with those from a
single FLAG-tag purification [26] and 30 proteins from
a BAP-tag/FLAG-tag tandem affinity purification [28].
Hence, the tag used and the accompanying purification
conditions change the type of interactors discovered,
and the overlap is apparently small.
Oct4 interactors indicate Oct4 engagements with multiple
cellular mechanisms
Of the 33 proteins, 24 were annotated by the PANTHER
database [32] and are significantly enriched for proteins
associated with binding activity [GO:5488] and catalytic
activity [GO:3824] (Figure 3B). This suggests that pro-
teins associated with Oct4 may determine its catalytic
activity to Oct4-mediated regulation. Association with
Oct4 could either lead to modifications of DNA and/or
other proteins or of Oct4 itself. The exact catalytic activ-
ities associated with our proteins include transcription
regulation, translation regulation, RNA splicing, helicase,
kinase, ligase, GTPase, nucleotidyltranferase, oxidoreduc-
tase and transferase activities (Table 3). These activities
provide a hint of the possible mechanisms that Oct4
employs. To better understand the developmental impact
of these Oct4-associated proteins, we combed the Mouse
Genome Informatics database for the loss-of-function
phenotypes associated with the genes of these proteins.
Known developmental defects are present in approxi-
mately 25% (9 of 33) of these interactors (Table 3). Aptly,
all of the three transcription factors with loss-of-function
phenotypes showed defects in fertility or inner cell mass
formation, which is in agreement with the developmental
stages in which Oct4 is known to be most essential
[5,33,34]. Another six proteins not associated with tran-
scription (Table 4) showed a range of phenotypes which
could occur through either direct or indirect association
with Oct4. Notably, Rad50 was a DNA repair protein
that, in hypomorphic mutants, revealed a predisposition
toward cancer, loss of spermatogenic stem cells and loss
of hematopoietic stem cells. This suggests that Rad50
could facilitate Oct4 in its transcriptional regulatory role
to control stem cell replication.
Novel transcriptional regulators coenriched with Oct4
As Oct4 is a transcription factor expected to interact
with other transcription factors in a modular fashion to
effect transcription regulation, we were most interested
in the proteins with a role in transcription regulation.
Five proteins, Fubp3, Fus, Psip1, Tardbp and Top2a,
were annotated by the DAVID and/or PANTHER data-
b a s e sa sp r o t e i n sw i t har o l ei nt r a n s c r i p t i o nr e g u l a t i o n
(Table 4). Of these five proteins, Top2a has been
reported to be an Oct4 interactor [26], while the other
four proteins have yet to be reported.
Discussion
Understanding the transcriptional regulatory role of Oct4
allows for the control of embryonic or induced pluripotent
stem cell applications [35]. As a master regulator, Oct4 is
already present in the unfertilized egg via maternal tran-
scripts to modulate gene expression from the earliest
stages of embryonic development. To coordinate gene reg-
ulation both positively and negatively in the dynamic and
temporal stages of development, Oct4 presumably must
interact with multiple functional modules involved in dif-
ferent areas of cellular regulation. Insights into such regu-
latory mechanisms of Oct4 can come from understanding
the Oct4 protein interaction network.
Previous studies on Oct4 have employed transgenic
methods that introduced a tagged Oct4 into ES cells.
While care has been taken to ensure that the level of extra
Oct4 does not exceed 50% of the endogenous level, an
increase in Oct4 is unavoidable. Therefore, all previous
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a
Gene
name
Entrez
Gene ID
Description Catalytic activity based on PANTHER CBP FLAG HIS S
Pou5f1 18999 POU domain, class 5, transcription factor 1 2.0 7.0 12.0 Exc
Cell cycle associated
Cdk1 12534 Cyclin-dependent kinase 1 Kinase 0.7 0.7 Exc Exc
Smc2 14211 Structural maintenance of chromosome 2 0.8 Exc Exc
Rad50 19360 RAD50 homolog (Saccharomyces cerevisiae) Exc Exc 1.3
Nup43 69912 Nucleoporin 43 Exc Exc 1.2
Metabolic processing
Trip12 14897 Thyroid hormone receptor interactor 12 9.0 Exc 0.5
Ribonucleoprotein complex
Ddx1 104721 DEAD (Asp-Glu-Ala-Asp) box polypeptide 1 Helicase, translation initiation 0.5 Exc Exc
Dhx15 13204 DEAH (Asp-Glu-Ala-His) box polypeptide 15 Helicase 0.6 3.0 22.5
Nop56 67134 Nucleolar protein 5A Exc Exc
RNA and protein transport and localization
Kpna2 16647 Karyopherin (importin) a2 Exc Exc
Nup93 71805 Nucleoporin 93 1.6 4.0 Exc
Nup85 445007 Nucleoporin 85 Transferase 3.5 Exc
Nop58 55989 Nucleolar protein 5 1.8 Exc Exc
Nup107 103468 Nucleoporin 107 3.3 Exc 0.8
Rcc1 100088 Regulator of chromosome condensation 1 Ligase, small GTPase regulator, guanyl-
nucleotide exchange factor
Exc 3.0
Thoc4 21681 THO complex 4 Exc Exc
Lbr 98386 Lamin B receptor Oxidoreductase Exc 3.5
Nup153 218210 Nucleoporin 153 Exc Exc
Nup155 170762 Nucleoporin 155 9.5 3.6 0.9
Tjp2 21873 Tight junction protein 2 2.0 Exc 0.5 Exc
Xpo1 103573 Exportin 1, CRM1 homolog (yeast) 3.0 Exc
RNA processing
Eftud2 20624 Elongation factor Tu GTP binding domain containing 2 Nucleotidyltransferase, GTPase,
translation initiation and elongation
0.5 4.3 0.8 Exc
U2af2 22185 U2 small nuclear ribonucleoprotein auxiliary factor 2 Exc Exc
Syncrip 56403 Synaptotagmin binding, cytoplasmic RNA interacting
protein
RNA splicing factor, transesterification
mechanism
5.0 3.0
Signal transduction
Cul4b 72584 Cullin 4B Exc Exc
Rsu1 20163 Ras suppressor protein 1 Exc Exc
SWI/SNF Complex
Smarcd1 83797 SWI/SNF-related, matrix-associated, actin-dependent
regulator of chromatin, subfamily d, member 1
1.0 6.0 1.0 Exc
Transcriptional regulation
Fubp3 320267 Far upstream element (FUSE) binding protein 3 3.3 4.0 Exc
Fus 233908 Fusion, derived from t(12;16) malignant liposarcoma RNA splicing factor, transesterification
mechanism
Exc Exc
Pelp1 75273 Proline, glutamic acid and leucine rich protein 1 Exc Exc 0.6
Psip1 101739 PC4 and SFRS1 interacting protein 1 2.5 Exc 4.0
Tardbp 230908 TAR DNA binding protein RNA splicing factor, transesterification
mechanism
0.6 5.0 Exc 2.0
Top2a 21973 Topoisomerase (DNA) IIa 3.7 1.8 0.7 4.0
Translational regulation
Igf2bp1 140486 Insulin-like growth factor 2 mRNA binding protein 1 RNA splicing factor, transesterification
mechanism
Exc Exc
aThe fold change of spectral counts of proteins from tag sample relative to wild-type sample is shown. Exc represents proteins that are seen exclusively in the
tag sample.
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ES cells. Hence, there is a dilemma with regard to keeping
the exogenous tagged Oct4 as low as possible to avoid
changing cell fate and making it high so that the purifica-
tion yield is better. Since our strategy does not change the
endogenous level of Oct4, we can have all the Oct4 pre-
sent physiologically contribute to the purification yield.
Indeed, we can get detectable Oct4 by using LC-MS/MS
with a low starting material level of 400 μgo fn u c l e a r
extract to get a signal of 11 spectra for Oct4 in the tag
purification and no signal in the wild-type control. This is
a significant reduction compared to what is required (50
to 100 mg) when tagged Oct4 is expressed as a low per-
centage of total Oct4 [36,37]. Also, since the endogenous
Oct4 is modified, the presence of untagged Oct4 acting as
a competitor for interactors is reduced.
While keeping Oct4 to its endogenous level is impor-
tant, no previous study has addressed a separate concern
that the tags used may impede the function of Oct4. We
tested two different tags in animals and found that the
classically used NTAP tag [38,39], comprising two pro-
tein A and one calmodulin-binding protein, prevents
Oct4 from driving embryonic development normally.
This information is especially useful for future work
involving gene tagging in both in vitro and in vivo
studies.
Three of four previous reports on Oct4 protein interac-
tion network used the FLAG tag in their approach. The
protein interactors found showed overlaps, lending confi-
dence to what are identified as true Oct4 interactors.
However, the use of a similar tag means that common
contaminants raised from a specific affinity purification
will also be repeatedly identified. Although tandem affinity
tags have previously been used [26,28], the number of pro-
teins found was lower than when single purifications are
used, suggesting that the inclusion of different tags can
produce a low overlap. One problem with tandem affinity
purification is the loss of yield as the number of steps and
experimentation time increase. To overcome this, we sim-
ply performed the purifications using different tags on
fresh ES cell samples and performed in silico tandem affi-
nity purification instead. This method allowed us to dis-
cover a total of 33 proteins using a low amount of starting
material (400 μg of nuclear extract) per purification.
In the online discussion by Pardo et al. [26] following
his publications on Oct4 interactors, this study group
suggested that heterogeneity in data sets can arise from
the cell line, the tagging strategy and particularly the
Figure 3 Profile of Oct4-associated protein. (A) Overlap of Oct4-
associated proteins identified in three different studies. The three
proteins that were shared between our Oct4 interactor lists, as well
as the Oct4-associated proteins identified by Pardo et al. [26], were
cullin 4B, importin subunit a2 and DNA topoisomerase 2a. Cheong
(present study); van den Berg [27]. (B) Gene ontology molecular
function of Oct4-associated protein according to the PANTHER
database.
Table 3 Phenotypes for loss of function of Oct4-associated transcriptional regulators
Protein Biological process Loss-of-function phenotype
Psip1 Transcription factor activity (PANTHER) Perinatal death (survivors show reduced fertility)
Tardbp Transcription factor activity (PANTHER) Embryonic lethality before somite formation with impaired inner
cell mass proliferation
Fus Positive regulation of transcription, DNA-dependent (DAVID),
transcription factor activity (PANTHER)
High neonatal mortality, and male sterility associated with lack
of chromosomal pairing
Top2a Positive regulation of transcription, DNA-dependent (DAVID) Nil
Fubp3 Positive regulation of transcription, DNA-dependent (DAVID) Nil
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list of interactors from the previous data sets, we tested
whether we could find novel interactors that bind to
Oct4 under different purification procedures using dif-
ferent tags from different cell lines. Although our
approach for protein extraction is similar to that of van
den Berg et al., our purification procedure following
protein extraction is different from those used in studies
by both van den Berg et al. [27] and Pardo et al. [26].
Additionally, we included a different combination of
tags for analysis. Using purification buffers for each affi-
nity tag that differ by parameters including ionic charge,
pH and the use of detergents, we intended to identify a
group of Oct4 interactors that were robustly identified
across varying conditions. These would be representative
of stalwart Oct4 interactions that could occur despite
the microenvironments that might arise in a cell. Also,
by considering only interactors that remained bound to
Oct4 under at least two different purification proce-
dures, we ensured that these interactions were not an
artefact of a specific purification procedure alone.
The focus of Oct4 interaction has been on chromatin
modifiers and transcriptional factors. With the use of
different approaches of purification, the majority of our
proteins showed other catalytic activities in addition to
transcriptional regulation. These include helicases,
ligases and RNA processing. Oct4 may recruit these
enzymes to modify itself or its associated proteins as an
additional means of regulation. Consistent with this
hypothesis is a report that Oct4 associates with the gly-
cosylating enzyme Ogt [27], suggesting that posttransla-
tional and splicing activities should not be overlooked in
considering Oct4 function. Indeed, Oct4 and other tran-
scription factors have been shown to regulate their
activity via O-GlcNAc modification [40-42]. Sumoylation
of Oct4 has also been reported to enhance its stability,
DNA binding and transactivation [43]. In a separate
study, Oct4 was reported to be ubiquitinated by Wwp2,
an E3 ubiquitin ligase [44]. Beyond modification of Oct4
activity levels, association with enzymes could give Oct4
the ability to modify DNA or other proteins. Potentially,
Oct4-associated helicases could be recruited to Oct4-
mediated transcriptional sites to keep the genome stable.
In view of the fact that ES cells and embryos are both
systems that require rapid DNA replication and tran-
scription [45], there is a need for helicases to keep the
genome stable when replication and transcriptional
complexes collide [46].
In addition to transcription-related activities, Oct4 also
affiliates with proteins involved in cell cycle regulation.
Cdk1 has previously been established in an Oct4 interac-
tion network [28] and is critical for the self-renewal of ES
cells [47]. Because of the unique cell cycle phasing of ES
cells with a short G1/S phase that promotes rapid prolif-
eration [48-50], the coupling of Oct4 activity with cell
cycle kinases such as Cdk1 may be necessary for rapid and
direct coordination of genomic activity with cell division,
failing which apoptosis may occur, as shown by ES cells
depleted of Cdk1 [47]. A separate Oct4 interactor discov-
ered in our study, Smc2, forms part of the condensins I
and II protein complexes required for proper DNA com-
paction during the interphase [51,52]. An RNA interfer-
ence screen in ES cells identified Smc2 as a protein
essential for proper chromosomal compaction in ES cells,
and a deficiency in Smc2 results in metaphase arrest in
these cells [53]. As ES cells are known to maintain much
of their chromatin in a heterochromatin state [54], there is
a significant role for Oct4 in mediating both epigenetic
machinery and condensin complexes to enable the
removal of activating histone modifications that can per-
turb proper compaction for mitosis.
Cul4b has also previously been identified as an Oct4
interactor [26] and is an E3 ubiquitin ligase [55]. Interest-
ingly, like Oct4, Cul4b is involved in Wnt signaling through
its repression of nuclear b-catenin levels that can otherwise
serve as a positive factor for differentiation [56]. Separately,
Oct4 and Cul4b have also been shown to interact with b-
catenin in immunoprecipitated complexes [56-58].
In addition to the role of Oct4 in cell cycle regulation
and inhibition of differentiation through the Wnt path-
way, it appears that Oct4 also associates with a number
of proteins involved in nuclear transport. While Kpna2
is a previously known Oct4 interactor [59] itself, Kpna2
and another novel Oct4 interactor, Rcc1, are both
Table 4 Phenotypes for loss of function of Oct4-associated proteins that are not known to be transcriptional
regulators
Gene Loss-of-function phenotype
Cdk1 Death prior to embryonic day 1.5
Igf2bp1 Increased neonatal lethality associated with multiple abnormalities
Lbr Impaired growth and skin defects
Nup155 Embryonic lethality associated with atrial fibrillation
Rad50 Embryonic death. Hypomorphic mutant shows predisposition toward cancer and loss of spermatogenic and hematopoietic stem cells,
leading to death.
Tjp2 Embryonic lethality associated with gastrulation defect
Cheong et al. Stem Cell Research & Therapy 2011, 2:26
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Page 9 of 11specifically involved in the nuclear import of proteins
[60]. In our study, various nucleoporins were also found
to associate with Oct4, which suggests that a complex
comprising nuclear pore proteins supporting factors
such as Kpna2 and Rcc1 work in tandem with Oct4,
although their imported cargo is as yet unclear. Given
the known link between Rcc1 and chromatin [61], it is
highly plausible that Oct4 utilizes Rcc1 as an intermedi-
ary between the current chromatin state and the trans-
port of necessary proteins for gene expression from
their cytosolic compartment.
The diversity in function of novel and known Oct4
interactors identified in our work clearly highlights the
need for a multifaceted approach for the completion of
the Oct4 interaction network. We believe that our use of
endogenous tagging methods and a combined in silico
analysis of identified proteins from different purification
conditions serves as a resource for research in this direc-
tion. While future work should include validation of the
interactors and a detailed investigation into the molecular
mechanism of each interactor, we are confident that our
present findings are of great value in expanding our frame-
work for understanding Oct4 interactions beyond tran-
scriptional control alone.
Conclusions
In summary, we have used endogenously tagged Oct4 to
study its interaction under physiological Oct4 levels. The
use of multitag purification platforms allowed for a wide
scope in the discovery of interactors. The proteins identi-
fied in this study include novel transcription factor inter-
actions and a demonstrated role for Oct4 in ES cells that
involves catalytic activities other than transcriptional
regulation.
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